ERBB2 and cancer: We found that the luminal B cancer subtype is associated with low enhancement of the intratumour (relative to the corpus mamma), and high enhancement of the intratumour (relative to the peritumour) independently predicts the HER2 + cancer subtype, the enhancement pattern may be related to its different components of intratumour and peritumour.